2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide

C18H18N4O5S2 — CID 74736874

IUPAC2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide
SMILESO=C(Nc1nccs1)C1CC(O)C(O)C2N=C(Nc3ccc4c(c3)OCO4)SC12
InChIInChI=1S/C18H18N4O5S2/c23-10-6-9(16(25)22-17-19-3-4-28-17)15-13(14(10)24)21-18(29-15)20-8-1-2-11-12(5-8)27-7-26-11/h1-5,9-10,13-15,23-24H,6-7H2,(H,20,21)(H,19,22,25)
InChIKeyAAMPCCBFFSRZFO-UHFFFAOYSA-N
MW434.50 g/mol
LogP1.50
Rot. Bonds3

About 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide

2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide (PubChem CID 74736874) has the molecular formula C18H18N4O5S2 and a molecular weight of 434.50 g/mol. Its IUPAC name is 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide.

Molecular Properties

Compound Name2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide
PubChem CID74736874
Molecular FormulaC18H18N4O5S2
Molecular Weight434.50 g/mol
Exact Mass434.07
IUPAC Name2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide
SMILESO=C(Nc1nccs1)C1CC(O)C(O)C2N=C(Nc3ccc4c(c3)OCO4)SC12
InChIInChI=1S/C18H18N4O5S2/c23-10-6-9(16(25)22-17-19-3-4-28-17)15-13(14(10)24)21-18(29-15)20-8-1-2-11-12(5-8)27-7-26-11/h1-5,9-10,13-15,23-24H,6-7H2,(H,20,21)(H,19,22,25)
InChIKeyAAMPCCBFFSRZFO-UHFFFAOYSA-N
XLogP1.50
TPSA125.30 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds3
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500434.50
LogP ≤ 51.50
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Analyze 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide?
The IUPAC name of 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide (CID 74736874) is 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide.
What is the SMILES notation for 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide?
The canonical SMILES for 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide is O=C(Nc1nccs1)C1CC(O)C(O)C2N=C(Nc3ccc4c(c3)OCO4)SC12.
What is the InChIKey of 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide?
The InChIKey is AAMPCCBFFSRZFO-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H18N4O5S2/c23-10-6-9(16(25)22-17-19-3-4-28-17)15-13(14(10)24)21-18(29-15)20-8-1-2-11-12(5-8)27-7-26-11/h1-5,9-10,13-15,23-24H,6-7H2,(H,20,21)(H,19,22,25).
What are the key properties of 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide?
2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide has a molecular weight of 434.50 g/mol, XLogP of 1.50, 3 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(1,3-benzodioxol-5-ylamino)-4,5-dihydroxy-N-(1,3-thiazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,3-benzothiazole-7-carboxamide is sourced from PubChem (CID 74736874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).